BioMarin Pharmaceutical Inc. (BMRN) Social Stream



BioMarin Pharmaceutical Inc. (BMRN): $84.76

1.89 (+2.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BMRN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Biomarin Pharmaceutical Inc (BMRN) Price Targets From Analysts

Use the tables below to see what analysts covering Biomarin Pharmaceutical Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 15 $152 $82 $108.642 $79.56 36.55%
2021-11-15 15 $152 $82 $108.928 $79.56 36.91%
2021-11-22 15 $152 $82 $109.357 $79.56 37.45%
2022-01-05 15 $155 $88 $111.5 $79.56 40.15%
2022-01-06 15 $155 $88 $112.214 $79.56 41.04%
2022-01-21 15 $155 $88 $112.571 $79.56 41.49%
2022-02-25 15 $155 $88 $112.857 $79.56 41.85%
2022-02-28 13 $155 $88 $115.75 $79.56 45.49%

The Trend in the Analyst Price Target


BMRN's average price target has moved down $5.29 over the prior 21 months.

Over the past 47 weeks, BMRN's average upside potential has been 35.76%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 13 183 81 107.11 77.07 38.98%
2021-05-22 21 169 82 107.78 78.10 38%
2021-07-10 20 161 82 107.11 83.62 28.09%
2021-08-05 22 165 81 107.74 77.93 38.25%
2021-09-20 20 165 81 110.83 77.38 43.23%

BMRN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.46 10 0 3 0 0 13

The Trend in the Broker Recommendations


BMRN's average broker recommendation rating improved by 0.37 over the prior 123 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Biomarin Pharmaceutical Inc's number of analysts covering the stock is higher than 935.41% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Biomarin Pharmaceutical Inc's average analyst price target is greater than 955.23% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Biomarin Pharmaceutical Inc's upside potential (average analyst target price relative to current price) is greater than 207.49% of them.
  • In terms of how Biomarin Pharmaceutical Inc fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -741.2% of that group.

In the Pharmaceutical Products industry, BHC, BGNE, and BAYRY are the three stocks most similar to Biomarin Pharmaceutical Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for BMRN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5223 seconds.